Saarland University
Also known as: Children`s Medical Hospital, University of Homburg/Saar, Homburg/Saar, Germany | Department of Clinical Chemistry, University of Saarland | Department of Neurology University Homborg Hospital of the Saarland, Germany | Dept. of Psychiatry and Psychotherapy, The Saarland University Hospital | Dept of Urology, Saarland University | Institute of Forensic Psychology and Psychiatry, University of Saarland | Medical Faculty of the University of the Saarland and Hospitals of the City of Cologne | Saarladnd University, Department of Neurology | Saarland University | Saarland University Hospital | Saarland University Medical Center | Saarland University Medical Center, Clinic for Radiotherapy and Radiooncology | Saarland University Medical Centre | Saarland University, Saarland University Hospital | Universitaetsklinikum des Saarlandes | Universität des Saarlandes | Universität des Saarlandes, EEAST | Universitatskliniken des Saarlandes | Universitatskliniken des Saarlandes, Homburg, Germany | University des Saarlandes | University Hospital Homburg/Saar | University Hospital of Saarland, Dpt. of Internal Medicine IV, Div. of Nephrology and Hypertension | University hospital of the Saarland | University Hospital of the Saarland | University Hospital, Saarland | University of Saarland | University of the Saarland
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2000Last known activity
Jul 31, 2025
Timeline
1940s
- Jan 1, 1948
Saarland University— Founded
Drugs by trial phase (52 distinct, 47 trials)
Phase 4 (9 own, 0 via acquisition)
Phase 3 (27 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Other trials (9 own, 0 via acquisition)
Indications
Studied for
- Aggression
- Alzheimer Disease
- Anemia
- Anemia, Iron-Deficiency
- Arteriosclerosis
- Atrial Fibrillation
- Attention Deficit Disorder with Hyperactivity
- Carcinoma
- Carcinoma, Transitional Cell
- Coronary Artery Disease
- Coronary Disease
- Coronary Restenosis
- Dementia
- Erectile Dysfunction
- Essential Hypertension
- Heart Diseases
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hepatitis C, Chronic
- Hyperkinesis
- Hypertension
- Infections
- Inflammation
- Influenza, Human
- Kidney Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Non-Hodgkin
- Melanoma
- Myocardial Ischemia
- Neuritis
- Optic Neuritis
- Pancreatic Neoplasms
- Photosensitivity Disorders
- Prostatic Neoplasms
- Raynaud Disease
- Recurrence
- Telangiectasia, Hereditary Hemorrhagic
- Telangiectasis
- Urinary Bladder Neoplasms
- Uveal Neoplasms
- Wilms Tumor
Recent trials (50)
- NCT07026474Lead sponsorPhase 3Jul 31, 2025
- NCT06223711Lead sponsorPhase 2Oct 6, 2023
- NCT05820841Lead sponsorPhase 3Jun 7, 2023
- NCT05820841CollaboratorPhase 3Jun 7, 2023
- NCT05820841Overall official - principal investigatorPhase 3Jun 7, 2023
- NCT05820841OfficialPhase 3Jun 7, 2023
- NCT05651464Lead sponsorN/AJan 1, 2023
- NCT05651464Overall official - principal investigatorN/AJan 1, 2023
- NCT05651464Reponsible party - principal investigatorN/AJan 1, 2023
- NCT05433116Lead sponsorPhase 2Oct 31, 2022
- NCT05433116OfficialPhase 2Oct 31, 2022
- NCT04654312Overall official - principal investigatorPhase 1Dec 1, 2020
- NCT04654312Lead sponsorPhase 1Dec 1, 2020
- NCT03366272OfficialPhase 2/Phase 3Dec 5, 2017
- NCT03366272Overall official - principal investigatorPhase 2/Phase 3Dec 5, 2017
Details
- Founded
- Saarbrucken, DE Jan 1, 1948
- Last known activity
- Jul 31, 2025